argenx adds two non-executive directors to its board

argenx SE (Nasdaq: ARGX) announced the results of an Extraordinary General Meeting of Shareholders and the appointment of Thomas M. Brakel and Khurem Farooq as non-executive directors to its Board of Directors, according to a company statement dated September 17, 2026.

Tim Van Hauwermeiren, Chairperson of the Board of argenx, commented on the appointments: "We welcome Tom and Khurem to the Board and look forward to learning from their combined years of leadership and expertise. As we look ahead to Vision 2030 and beyond, we are building a company, and a board, with the strength and perspective to sustain and grow what argenx contributes to patients, science, and society for decades to come."

Voting results and documents related to the shareholders' meeting are to be made available on the company's investor relations website.

You May Also Be Interested In

• BMO Capital Starts HCA Healthcare Inc (HCA) at Outperform
• Texas Capital Securities Starts Porch Group Inc. (PRCH) at Buy
• Blue Owl Credit Income raises $1.3B through notes offering and credit facility